arginine has been researched along with Carcinoma in Situ in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biermann, K; Eckert, D; Gillis, AJ; Jäck, HM; Looijenga, LH; Müller, AM; Nettersheim, D; Schorle, H; Steger, K | 1 |
| Herzog, RE | 1 |
| Baber, GB; Boyd, JC; Malcolm, EK; Stoler, MH | 1 |
| Hopster, D; Jacobs, IJ; Rosenthal, AN; Ryan, A | 1 |
| Lum, BL | 1 |
| Hofmann, W; Langkopf, B | 1 |
| Pavone-Macaluso, M | 1 |
1 review(s) available for arginine and Carcinoma in Situ
| Article | Year |
|---|---|
Intravesical chemotherapy of superficial bladder cancer.
Topics: Absorption; Animals; Antineoplastic Agents; BCG Vaccine; Carcinoma in Situ; Doxorubicin; Endoscopy; Ethoglucid; Humans; Hydrogen-Ion Concentration; Mitomycin; Mitomycins; Molecular Weight; Neoplasm Recurrence, Local; Teniposide; Thiotepa; Urinary Bladder Neoplasms | 1983 |
6 other study(ies) available for arginine and Carcinoma in Situ
| Article | Year |
|---|---|
Expression of BLIMP1/PRMT5 and concurrent histone H2A/H4 arginine 3 dimethylation in fetal germ cells, CIS/IGCNU and germ cell tumors.
Topics: Arginine; Carcinoma in Situ; Cell Line, Tumor; Female; Fetus; Germ Cells; Histones; Humans; Male; Methylation; Neoplasms, Germ Cell and Embryonal; Positive Regulatory Domain I-Binding Factor 1; Pregnancy; Protein Methyltransferases; Protein-Arginine N-Methyltransferases; Repressor Proteins; Testicular Neoplasms; Testis | 2008 |
Cytophotometric determinations of DNA, histone, arginine, lysine, and their concentrations in eu- and heterochromatin of the cell nucleus of dysplasias, carcinoma in situ, and carcinoma of the human cervix uteri.
Topics: Arginine; Carcinoma; Carcinoma in Situ; Cell Nucleus; Chromatin; DNA, Neoplasm; Female; Heterochromatin; Histones; Humans; Lysine; Mathematics; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms | 1982 |
Polymorphism at codon 72 of p53 is not associated with cervical cancer risk.
Topics: Adenocarcinoma; Alleles; Arginine; Carcinoma in Situ; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Codon; DNA, Neoplasm; Female; Gene Frequency; Homozygote; Humans; Neoplasm Invasiveness; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms | 2000 |
p53 codon 72 polymorphism in vulval cancer and vulval intraepithelial neoplasia.
Topics: Adult; Arginine; Carcinoma in Situ; Carcinoma, Squamous Cell; Codon; Female; Genes, p53; Humans; Papillomaviridae; Papillomavirus Infections; Polymorphism, Genetic; Tumor Virus Infections; Vulvar Neoplasms | 2000 |
[Possibilities and value of intracavitary and systemic chemotherapy of bladder cancer].
Topics: Antineoplastic Agents; Carcinoma in Situ; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Fluorouracil; Humans; Methotrexate; Mitomycin; Mitomycins; Teniposide; Thiotepa; Urinary Bladder; Urinary Bladder Neoplasms | 1982 |
Chemotherapy of bladder tumours.
Topics: Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Papillary; Humans; Neoplasm Metastasis; Papilloma; Recurrence; Teniposide; Thiotepa; Urinary Bladder Neoplasms | 1978 |